Surmodics | SRDX - Ordinary Share Capital


Surmodics reported $716K in Ordinary Share Capital for its fiscal quarter ending in September of 2024.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Align Technology USD 71.75M 736K Dec/2025
Anika Therapeutics USD 143K 1000 Mar/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Baxter International USD 514.28M 168.72M Dec/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
EDAP TMS EUR 37.39M 0 Sep/2025
Edwards Lifesciences USD 580.7M 7.2M Sep/2025
Haemonetics USD 46.83M 82K Dec/2025
Heron Therapeutics USD 1.52M 14K Sep/2024
J&J USD 2.41B 584K Sep/2025
Merit Medical Systems USD 59.29M 72K Sep/2025
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Nektar Therapeutics USD 19K 0 Sep/2024
Option Care Health USD 156.86M 6.89M Dec/2025
Stryker USD 382.4M 93K Dec/2025
Surmodics USD 716K 4K Sep/2024
Trinity Biotech USD 385.2M 382.82M Jun/2025